5-METHYL-3-PYRIDIN-4-YL-ISOXAZOLE-4-CARBOXYLIC ACID
|
- $188 - $465
- Product name: 5-METHYL-3-PYRIDIN-4-YL-ISOXAZOLE-4-CARBOXYLIC ACID
- CAS: 90771-23-6
- MF: C10H8N2O3
- MW: 204.18
- EINECS:
- MDL Number:MFCD06589776
- Synonyms:AKOS BBS-00004593;5-METHYL-3-PYRIDIN-4-YL-ISOXAZOLE-4-CARBOXYLIC ACID;5-Methyl-3-(4-pyridinyl)-4-isoxazolecarboxylic acid;4-Isoxazolecarboxylic acid, 5-methyl-3-(4-pyridinyl)-;5-Methyl-3-(pyridin-4-yl)-1,2-oxazole-4-carboxylic acid;5-Methyl-3-(4-pyridyl)isoxazole-4-carboxylic Acid
4 prices
Selected condition：
Brand
- AK Scientific
- Matrix Scientific
- TRC
Package
- 100mg
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number2809AF
- Product description5-Methyl-3-pyridin-4-yl-isoxazole-4-carboxylicacid
- Packaging1g
- Price$465
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018600
- Product description5-Methyl-3-pyridin-4-yl-isoxazole-4-carboxylic acid
- Packaging500mg
- Price$188
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018600
- Product description5-Methyl-3-pyridin-4-yl-isoxazole-4-carboxylic acid
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM643530
- Product description5-methyl-3-pyridin-4-yl-isoxazole-4-carboxylicAcid
- Packaging100mg
- Price$220
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 2809AF | 5-Methyl-3-pyridin-4-yl-isoxazole-4-carboxylicacid | 1g | $465 | 2021-12-16 | Buy |
| Matrix Scientific | 018600 | 5-Methyl-3-pyridin-4-yl-isoxazole-4-carboxylic acid | 500mg | $188 | 2021-12-16 | Buy |
| Matrix Scientific | 018600 | 5-Methyl-3-pyridin-4-yl-isoxazole-4-carboxylic acid | 1g | $308 | 2021-12-16 | Buy |
| TRC | M643530 | 5-methyl-3-pyridin-4-yl-isoxazole-4-carboxylicAcid | 100mg | $220 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|